Related Experiment Video
Updated: Oct 29, 2025

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
[Swedish osteoarthritis treatment at the forefront]
Håkan Nero1, Anna Cronström2, Allan Abbott3
1med dr, leg fysioterapeut, biträdande forskare, ortopedi, institutionen för kliniska vetenskaper, Lunds universitet.
Abstract:
Osteoarthritis (OA) is a highly prevalent group of disorders and among the most common causes of chronic pain and disability globally. First-line evidence-based treatments for hip and knee OA, two of the most common variants, are available in Sweden with the potential for wide national reach through face-to-face and digital platforms. Research results suggest important reductions in symptoms in patients with knee or hip OA. Despite evidence, availability and low cost, first-line evidence-based treatments are not utilized to the full extent to reduce the burden of OA.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Rheumatic Heart Disease III: Medical Management
Alzheimer's Disease: Treatment
Atherosclerosis III: Management
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

